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Abstract
Reaction of the melanotropin hormone analogs [Nle4,D-Phe7]-K-MSH and [Nle4,D-Phe7]-K-MSH(4^10), which were
extended at their N-terminus by a thiol-functionalized spacer arm, with preformed liposomes containing thiol-reactive
(phospho)lipid derivatives resulted in the aggregation of the vesicles and in a partial leakage of their inner contents. This
aggregation/leakage effect, which was only observed when the peptides were covalently conjugated to the surface of the
liposomes, was correlated with the fusion of the vesicles as demonstrated by the observed decrease in resonance energy
transfer between probes in a membrane lipid mixing assay. A limited fusion was confirmed by monitoring the mixing of the
liposome inner contents (formation of 1-aminonaphthalene-3,6,8-trisulfonic acid/p-xylene bis(pyridinium bromide)
complex). The membrane-active properties of the peptides could be correlated with changes in the fluorescence emission
spectra of their tryptophan residue, which suggested that after their covalent binding to the outer surface of the liposomes
they can partition within the core of the bilayers. A blue shift of 10 nm was observed for [Nle4,D-Phe7]-K-MSH which was
correlated with an increase in fluorescence anisotropy and with changes in the accessibility of the coupled peptide as assessed
by the quenching of fluorescence of its tryptophan residue by iodide (Stern^Volmer plots). These results should be related to
the previously described capacity of K-MSH, and analogs, to interact with membranes and with the favored conformation of
these peptides which, via a L-turn, segregate their central hydrophobic residues into a domain that could insert into
membranes and, as shown here, trigger their destabilization. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
K-Melanocyte-stimulating hormone (K-MSH; Ta-
ble 1B) binds with high a⁄nity to melanocortin G
protein-coupled receptors (MCR) and in humans at
least ¢ve subtypes of MCR have been identi¢ed in
various tissues and cells including melanocytes [1].
Although it is primarily responsible for the control
of skin pigmentation, this tridecapeptide is endowed
with many other biological and lesser de¢ned func-
tions such as in nervous system as a neurotransmitter
and in the immune system where it seems able to
modulate immune responses and in£ammatory pro-
cesses [2,3]. The occurrence of MCR as a membrane
marker of human melanoma cells [4] is also of great
interest as a target for the localization and therapy of
these malignant cells. Accordingly several strategies
of clinical relevance based on the use of K-MSH and
analogs as ligands for targeting melanoma cells have
been designed in e.g. scintigraphy and radioligand
constructs or delivery of chemotherapeutic agents
[1]. During recent decades much e¡ort has been de-
voted to elucidating the structure^activity of the mel-
anotropins. Thus, numerous analogs have been syn-
thesized including cyclized peptides leading to the
discovery of the paramount importance of the
‘core’ sequence His6-Phe-Arg-Trp9 for biological ac-
tivity [5,6]. Similarly the two- and three-dimensional
structures of K-MSH and analogs when bound to
their receptor has also been investigated and confor-
mations such as L-turns that involve this central
‘message’ region are presently invoked [7]. Early
on, ‘superpotent’ agonists have been developed
such as [Nle4,D-Phe7]-K-MSH ([NDP]-K-MSH, 1),
an analog of the natural hormone in which residues
at positions 4 and 7 have been substituted by non-
natural amino acids (Table 1B), and the truncated
analog [NDP]-K-MSH(4^10) (2) [5,6]. These peptides
are characterized by a higher a⁄nity for the melano-
cortin receptor and a lesser susceptibility to proteases
[8], and to explain their unusually long lasting bio-
logical e¡ect [9] an interaction with the lipid phase of
membranes was postulated (‘stickiness’ or ‘sequestra-
tion’). Indeed, several publications, mostly on model
systems such as liposomes, have clearly indicated
that K-MSH was able to interact and penetrate mem-
branes. A two-step process was described: an initial
electrostatic interaction between the positively
charged peptide with negatively charged (phospho)-
lipids of the membrane making it possible to reach
an appropriate local concentration is followed by the
penetration of the peptide in the hydrophobic core of
the bilayer [10^14]. No consequence for the mem-
brane structure of this penetration has, however,
been described.
During our recent work on the targeting of mela-
noma cells with liposomes carrying antitumor drugs
we have covalently coupled the two superpotent K-
MSH analogs 1 and 2 to the outer surface of pre-
formed vesicles according to a classical strategy out-
lined in Table 1A. This resulted in a net aggregation
of the liposomes and in the partial leakage of their
inner content. We have therefore undertaken a study
to better characterize and understand these activities.
The present work deals with these new properties of
K-MSH analogs which were found, in analogy to the
mode of action of membrane-active peptides [15^18],
to destabilize the bilayers of liposomes and trigger
their fusion. This behavior, which is only observed
when peptides are conjugated to the outer surface of
the vesicles, is reminiscent of the activity of fusion
peptide sequences of viral proteins which are also
associated with a membrane-anchored subunit [19].
The results described in this study add a new dimen-
sion to the potential of these quite unique bioactive
peptides which have been used e.g. to promote cat-
ionic lipid-based gene delivery [20].
2. Materials and methods
2.1. Materials
The 3-thiopropionate N-derivatives of NDP-
[NDP]-K-MSH (1) and [NDP]-K-MSH(4^10) (2)
were obtained from Neosystem (Strasbourg, France).
Egg yolk phosphatidylcholine (PC), phosphatidylglyc-
erol (PG), cholesterol (Chol), hydrogenated soybean
PC (PCH), 1,2-dipalmitoyl-sn-glycero-3-phosphati-
dylglycerol (DPPG) and £uorescein-5P-isothiocya-
nate-dextran 77 kDa were obtained from Sigma
(L’Isle d’Abeau Chesnes, France). 1,2-Dipalmitoyl-
sn-glycero-3-phosphatidylethanolamine (DPPE)-
PEG3-maleimide and DPPE-bromoacetyl derivatives
were prepared in our laboratory as described previ-
ously [21]. N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)-
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phosphatidylethanolamine (N-NBD-PE), N-(liss-
amine rhodamine B sulfonyl)-phosphatidylethanol-
amine (N-Rh-PE), 1-aminonaphthalene-3,6,8-trisul-
fonic acid (ANTS) (disodium salt) and p-xylene
bis(pyridinium bromide) (DPX) were purchased
from Molecular Probes. 5,6-Carboxy£uorescein
(Eastman-Kodak) and calcein (Prolabo) were puri-
¢ed respectively on Sephadex LH-20 (Pharmacia)
Table 1
Coupling of peptides to liposomes
aK-MSH analogs 1 and 2, derivatized at their N-terminus with thiol-functionalized linkers, were conjugated (see text) to preformed
liposomes containing thiol-reactive groups X such as maleimide or bromoacetyl (Table 2).
bThe linkers are underlined.
Table 2
Structure of thiol-reactive (phospho)lipid derivatives used in this study
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[22] or by recrystallization from ethanol/water. All
other reagents were of analytical grade. Ellman’s
method was used to determine thiol-reactive func-
tions [23].
2.2. Synthesis of lipid derivatives
BOP-PEG4-AcBr was prepared by coupling 2,3-
bis[(Z)-octadec-9-enyloxy]-(amino-11-trioxa-3,6,9-un-
decyl)-3-propane (BOP-PEG4-NH2) to N-succinimid-
yl bromoacetate [24] essentially as described by
Frisch et al. [21]. Rf 0.51 (CH2Cl2 :CH3OH, 9:1).
1H-NMR (CDCl3, 300 MHz) N 0.88 (t, CH3), 1.28
(d, 22 CH2), 1.50^1.60 (m, 2 CH2CH2O), 1.92^2.06
(m, 4 CH2CHNCH), 3.43^3.67 (m, CH2NHCO, 11
CH2O, (CH2)2CHO), 3.87 (s, CH2Br), 5.28^5.40 (m,
2 CHNCH), 7.10 (ls, NHCO). 13C-NMR (CDCl3, 75
MHz) major peaks at N 32.59 (CH2Br), 39.91
(CH2NHCO), 77.8 (CH2)2CHO), 129.80 and
129.91(CHNCH), 165.73 (CONH). High resolution
mass spectra (FAB) : m/z calculated for
C49H94NO7Br 889.20; found 890.6 (M+H). The
synthesis of DPPE-PEG45-Mal will be reported else-
where (Frisch et al.).
2.3. Preparation of liposomes
A solution of lipids in chloroform/methanol (9:1,
v:v) was evaporated and the resulting ¢lm dried
under high vacuum. The ¢lm was then rehydrated
in indicated bu¡ers at concentrations of 1^10 Wmol
lipid ml31 by vortexing and the resulting suspension
was sonicated (1 h at 25‡C), under a continuous £ow
of nitrogen, using a titanium probe-type sonicator
(Vibra Cell ; Sonics and Materials, Danbury, CT,
USA). Probe debris was removed by centrifugation.
When needed, the obtained liposomes were extruded
nine times through 0.1 Wm pore size polycarbonate
membranes (Nucleopore). In the case of liposomes
composed of PCH/DPPG/Chol/DPPE-PEG3-Mal
(70/20/50/10; molar ratios), the lipid ¢lm was rehy-
drated by ¢ve freeze/thawing cycles at 380‡C/+25‡C.
This preparation was then further sonicated (1 h) at
70‡C and extruded. These di¡erent procedures
yielded vesicles with a 110 þ 15 nm mean diameter
as determined by quasi-elastic light scattering (Coult-
er sub-micron particle analyzer; Coulter Electronics,
Hialeah, FL, USA). Liposomes loaded with 5(6)-car-
boxy£uorescein (CF), calcein, ANTS or DPX were
prepared and separated from free dyes by gel ¢ltra-
tion (Sephadex G75, Pharmacia). Liposomal concen-
trations were determined using the phosphate assay
[25].
2.4. Fluorescence and light scattering measurements
Fluorescence and light scattering were recorded in
a ratio mode, at 25‡C, on a SLM-8000 spectro-
£uorimeter computerized with a Biokine ASCII pro-
gram (Biologic, Claix, France). A stirring device en-
abled constant mixing of the medium and the
temperature was controlled with a thermostated cir-
culating water bath.
2.5. Determination of CF or calcein leakage
The £uorescence was recorded after addition,
under mild agitation, of the peptides (2:1 molar
excess peptide vs. surface-accessible thiol-reactive
functions) to dye-loaded liposomal suspensions
(50^500 WM phospholipid in given bu¡ers, ¢nal
volume: 1 ml, temperature: 25‡C). Excitation and
emission wavelengths were set at 490 and 520 nm,
respectively. To measure the total £uorescence inten-
sity corresponding to 100% dye release, 100 Wl of
Triton X-100 (5% w:v in HEPES or borate bu¡ers)
was added to the vesicles. The percentage of dye
release caused by the peptides was calculated using
the equation: (F3F0)U100/(Ft3F0), where F is
the £uorescence intensity measured in the presence
of the peptide and F0, Ft respectively the intensities
obtained before the addition of the peptides and
after Triton X-100 treatment [26]. Ft values were
corrected for dilutions caused by the Triton X-100
addition.
2.6. Vesicle aggregation
The aggregation was followed by monitoring the
right-angle light scattering of vesicle suspensions,
with excitation and emission monochromators of
the £uorimeter both set at 400 nm. The change of
scattered light, after addition of peptides, was re-
corded during 60^90 min at 25‡C.
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2.7. Rate of reaction of the peptides 1 or 2 with the
liposomal thiol-reactive functions
The composition of the liposomes used for this
study was PC/PG/Chol/DPPE-PEG3-Mal (65/20/50/
15) (L1) in 10 mM HEPES (pH 6.5 or 7.4) bu¡er
containing 140 mM NaCl (B1) for the maleimide
function and PC/Chol/BOP-PEG4-AcBr (85/50/15)
(L2) in 40 mM borate bu¡er containing 130 mM
NaCl (pH 9.0) (B2) for the bromoacetyl function.
Peptides 1 or 2 (90 nmol) were added to the vesicle
suspensions (100 WM phospholipids; ¢nal volume:
6 ml) at 25‡C. The reaction progress was measured
by determination at given times of residual thiols on
500 Wl aliquots with 1.5 ml Ellman’s reagent (2 mM
5,5P-dithiobis(2-nitrobenzoic acid) and 1 mM EDTA
in 0.2 M sodium phosphate bu¡er, pH 7.27) [23]. The
mixture was immediately ¢ltered through a 0.2 Wm
¢lter (Gelman Sciences) and the absorbance read at
412 nm against a blank obtained with liposomes in
the absence of peptides. A standard curve was estab-
lished with 2-mercaptoethanol for each bu¡er. The
rates were corrected for the spontaneous peptide oxi-
dation (dimerization) at each pH value [27].
To determine the yield of peptide coupling to the
outer surface of the vesicles, the conjugation step was
followed by the addition of a 10-fold excess of 2-
mercaptoethanol to deactivate the remaining thiol-
reactive functions. After 1 h of this treatment, the
liposomes were dialyzed extensively against a 10
mM HEPES bu¡er (pH 7.4) containing 145 mM
NaCl to eliminate unconjugated peptides and re-
agents. Estimation of liposome-associated peptides
was obtained by hydrolyzing an aliquot of the prep-
aration (100 Wl liposome suspension, 100 Wl 12 M
HCl, 110‡C, 12 h) followed by quanti¢cation of the
number of amino groups with £uorescamine [28].
Control liposomes (i.e. unconjugated liposomes)
were prepared similarly without the peptide coupling
step.
2.8. Tryptophan £uorescence measurements
The SLM-8000 spectro£uorimeter in the T-format
was used to measure the steady-state £uorescence
anisotropy r = (Ie3IP)/(Ie+2IP). The excitation wave-
length was 280 nm and 355 nm Schott interference
¢lters were used for the emitted light. A home-built
device ensured automatic rotation of the excitation
polarizer, allowing a continuous average measure-
ment of r. Tryptophan emission spectra was re-
corded, from 300 to 440 nm with an excitation wave-
length of 280 nm for the peptides, either free in
bu¡ers B1 and B2 or in the presence of control lipo-
somes PC/PG/Chol (80/20/50) and PC/Chol (100/50),
and for the peptides covalently coupled to the lipo-
somes L1 and L2. Trp £uorescence intensity mea-
surements were also performed in the presence of
potassium iodide. Increasing concentrations of KI
(from a 400 mM aqueous stock solution) were added
to 0.5 ml of B2 containing free peptide 1 and control
liposomes PC/PG/Chol (80/20/50) and to peptide 1
coupled to PC/PG/Chol/BOP-PEG4-AcBr liposomes
(with 75/20/50/5 molar ratios chosen to limit the ag-
gregation of the vesicles) in bu¡er B2. Potassium
chloride was added to bring a total salt concentra-
tion to a constant value of 200 mM for all samples
(¢nal volume 1 ml) [29]. The ¢nal pH was main-
tained at 9.0. The collisional quenching was assessed
with the Stern^Volmer relation, F0/F = Ksv[Q]+1,
where F0 is the £uorescence intensity in the absence
of I3 and F the observed intensity at a given concen-
tration [Q] of I3 ; Ksv is the Stern^Volmer quenching
constant. Ksv is readily obtained from the slopes of
plots F0/F vs. [Q]; this value decreases when the
probability of collision with the quencher decreases,
i.e. when the £uorophore is shielded from the
quencher. Fluorescence intensity was measured at
340 nm. Values were corrected for the vesicle blank
(scatter) when peptides were in the presence of lipo-
somes.
2.9. Liposome fusion assay by lipid mixing
Lipid mixing was monitored by the N-NBD-PE/N-
Rh-PE energy transfer assay [30]. Labeled liposomes
containing each probe at 0.9 mol% (vs. phospholip-
ids), which results in the quenching of the N-NBD-
PE £uorescence signal, were prepared and mixed in a
1:9 mol ratio with probe-free vesicles at a ¢nal phos-
pholipid concentration of 100 WM in B1 or B2, re-
spectively for the maleimide or bromoacetyl func-
tionalized thiol-reactive lipid derivatives. Liposome^
liposome lipid mixing/fusion was triggered by addi-
tion of peptide 1 or 2 and the probe di¡usion/dilu-
tion was evidenced by an increase of the N-NBD-PE
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£uorescence resulting from self-quenching relief [31].
The £uorescence before peptide addition was taken
as 0% and the 100% £uorescence was determined
using an equivalent concentration of vesicles contain-
ing 0.09 mol% of both probes (‘mock’ vesicles). The
excitation wavelength was 460 nm and the increase in
N-NBD-PE £uorescence, after addition of the pep-
tide, was monitored as a function of time at 525 nm.
2.10. Liposome fusion assay by internal content
mixing
The ANTS/DPX fusion assay was carried out as
described by Ellens et al. [32]. Liposomes L1 (100
WM phospholipids) contained either 25 mM ANTS,
95 mM NaCl and 10 mM HEPES bu¡er (pH 6.5), or
90 mM DPX, 55 mM NaCl and 10 mM HEPES
bu¡er (pH 6.5) were prepared. Control vesicles cor-
responding to a complete content mixing and which
contained 12.5 mM ANTS, 45 mM DPX, 75 mM
NaCl and 10 mM HEPES bu¡er (pH 6.5) were
also made. ANTS £uorescence intensity was moni-
tored at 505 nm (emission) using an excitation at 355
nm. For fusion assays a 1:1 molar ratio of DPX-
containing liposomes and ANTS-containing lipo-
somes in bu¡er B1 was used. The initial £uorescence
of the combined suspension was taken as 100% £uo-
rescence level (or 0% fusion). The decrease in £uo-
rescence triggered by peptide addition, due to con-
tents mixing and the formation of an ANTS/DPX
complex with reduced quantum yield, re£ected the
rate of the vesicle fusion. The £uorescence level cor-
responding to 100% of content mixing, i.e. 100%
leakage-free fusion, was determined from 100 WM
liposomes containing the coencapsulated ANTS and
DPX.
3. Results
3.1. Coupling of K-MSH peptide analogs to the
surface of liposomes
The conjugation of [NDP]-K-MSH(1^13) (1) and
[NDP]-K-MSH(4^10) (2) to the surface of vesicles
(Table 1) was performed according to a strategy we
have developed before for the preparation of lipo-
some-based synthetic vaccines [33,34]. Accordingly:
(i) the peptides were extended at their N-terminus by
a thiol-functionalized spacer arm; this was shown
before to bear no consequence on the a⁄nity of these
ligands for their receptor [35,36], (ii) thiol-reactive
derivatives (e.g. maleimide or bromoacetyl functions)
of phosphatidylethanolamine [21] or other lipophilic
anchors (see Table 2) were incorporated in the (phos-
pho)lipid composition of the liposomes, (iii) the con-
jugation of the thiolated peptides to the surface of
preformed liposomes was performed under mild and
well controlled pH and temperature conditions.
When using low proportions of thiol-reactive deriv-
atives in the preparation of the vesicles or short
spacer arms such as DPPE-AcBr, i.e. conditions
which limit vesicle aggregation (see below), the quan-
tity of peptide coupled to the liposomes represented
consistently 50% ( þ 5%) of the total amount of in-
corporated maleimide or bromoacetyl derivatives;
thus under these speci¢c conditions the coupling re-
actions were nearly quantitative with respect to any
thiol-reactive function exposed on the surface of the
vesicles.
3.2. Conjugation of K-MSH analogs triggers the
aggregation and leakage of liposomes ^
phenomenological aspects
When 1 was added to negatively charged unilamel-
lar liposomes (PC/PG/Chol/DPPE-PEG3-Mal) that
encapsulated CF or calcein, we were confronted
with a fast (min range) and extensive aggregation
of the vesicles (Fig. 1B), i.e. the suspension became
milky and in the most extreme cases this was fol-
lowed by the formation of precipitates. As assessed
by the increase in £uorescence, this was accompanied
by a partial release of the vesicle inner contents that
plateaued at about 15% of total dye release (Fig.
1A). Similar results, i.e. aggregation and leakage,
were observed with liposomes containing the same
proportion of BOP-PEG4-AcBr, another thiol-reac-
tive PE derivative that requires basic conditions (pH
9.0) to covalently react with the thiol function of the
peptide (Fig. 1A,B). In this case however, an in-
creased lag phase due to a slower peptide coupling
rate (see below) was observable. Because the K-MSH
analog used here carries a net positive charge, we
also veri¢ed the potential involvement of charge^
charge interactions in these e¡ects. Covalent cou-
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pling of peptide 1 to zwitterionic (neutral) liposomes
(PC/Chol/BOP-PEG4-AcBr) also provoked the ag-
gregation of the vesicles and their extensive leakage
(about 40%) (Fig. 1A,B). This rules out, a priori, that
electrostatic interactions play an important role in
the destabilization of these vesicles. We have also
tested the in£uence of the bilayer lipid packing
with liposomes such as PCH/DPPG/Chol/DPPE-
PEG3-Mal where the phospholipids carry saturated
fatty acids (Tcs 25‡C). On addition of peptide 1, an
immediate and extensive content release was also ob-
served with these vesicles (not shown).
Finally, we veri¢ed the e¡ect of pH on these phe-
nomena. The conformation of many membrane-ac-
tive peptides and their corresponding membrane-de-
stabilizing e¡ects are sensitive to pH [37]; thus many
virus-derived fusogenic peptides are only active
under acidic conditions [19,38]. In Fig. 2 are given
representative leakage time courses, as a function of
pH, of liposomes containing 15 mol% DPPE-PEG3-
Mal after addition of peptide 1. No pH threshold
value was observed between pH 5 and 7.4 and the
higher rates observed at pH 7.4 could be explained
by a faster coupling reaction between 1 and the mal-
eimide function [21,27].
These properties of K-MSH analog 1, which were
totally unpredicted, could not be reproduced with
control vesicles that lacked thiol-reactive lipids (PC/
PG/Chol) or with liposomes where the maleimide
function had been reacted ¢rst with e.g. 2-mercapto-
ethanol; in both cases the vesicles remained perfectly
Fig. 2. In£uence of pH on calcein leakage time course. Peptide
1 was added at a 2:1 molar ratio vs. surface-exposed thiol-reac-
tive functions to PC/PG/Chol/DPPE-PEG3-Mal (65/20/50/15)
liposomes (100 WM phospholipid; 25‡C), having encapsulated
50 mM calcein, in 10 mM sodium citrate bu¡er, 140 mM
NaCl, pH 5.0 (a) or 10 mM HEPES bu¡er, 140 mM NaCl, pH
6.5 (b) and 7.4 (c) (see Fig. 1A).
Fig. 1. Representative time courses of aggregation, leakage and
lipid mixing triggered by covalent coupling of 1 to the surface
of liposomes. Peptide 1 was added at a 2:1 molar ratio vs. sur-
face-exposed thiol-reactive functions to suspensions (25‡C) of:
(a) PC/PG/Chol/DPPE-PEG3-Mal (65/20/50/15) liposomes in 10
mM HEPES bu¡er, 140 mM NaCl, pH 6.5, (b) PC/PG/Chol/
BOP-PEG4-AcBr (65/20/50/15) and (c) PC/Chol/BOP-PEG4-
AcBr (85/50/15) liposomes in 40 mM sodium borate bu¡er, 130
mM NaCl, pH 9.0. Final (phospho)lipid concentration 100 WM
in 1 ml. (A) Leakage of CF (all vesicles contained 40 mM dye)
was monitored at 520 nm (excitation 490 nm) and is given as
% of the maximal dye release obtained in the presence of deter-
gent (see text). (B) Light scattering intensity increase due to ag-
gregation (at 400 nm). (C) Lipid mixing fusion assay. The lipo-
somes were mixed in a lipid molar ratio of 9:1 with vesicles of
same composition (i.e. labeled vesicles) containing both N-
NBD-PE and N-Rh-PE probes (each at 0.9 mol% vs. phospho-
lipids). Peptide 1 was added at time zero. In this probe dilution
assay the increase of N-NBD-PE £uorescence due to quenching
relief was monitored at 525 nm (excitation 460 nm). The maxi-
mal £uorescence (100%) was determined with a mixture of lipo-
somes containing each probe at appropriate concentrations (see
text).
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stable in the presence of free peptide 1. It seems
therefore that the covalent coupling of 1 to the sur-
face of the liposomes was responsible for these phe-
nomena.
3.3. Parameters in£uencing liposome aggregation
and leakage triggered by the coupling of
K-MSH analogs
3.3.1. Spacer arm length
We ¢rst studied the in£uence of the spacer arm
length between the peptide and the liposome surface.
The ¢rst alternative construct was PC/PG/Chol/
DPPE-AcBr (65/20/50/15) in which the thiol-reactive
derivative carries a very short linker (see Table 2).
Reaction with 1 also resulted in an aggregation that
was paralleled by a leakage of 5% of the dye. The
other spacer arm tested was carried by DPPE-
PEG45-Mal. When incorporated into PC/PG/Chol/
DPPE-PEG45-Mal (70/20/50/10) liposomes, this thi-
ol-reactive derivative was expected to ful¢ll a double
role: (i) because of the length of the PEG45 chain,
the peptide that is coupled to its distal end gains a
great spatial mobility, and (ii) the hydrophilic
PEG45-chain provides a property of ‘stealthiness’ to
the vesicles that carry it [39], i.e. these vesicles are
much less prone to aggregation and to destabiliza-
tion for example by opsonins. Coupling of 1 to these
liposomes resulted in an aggregation comparable to
that observed with vesicles containing DPPE-PEG3-
Mal but, in contrast to all other cases examined so
far, this phenomenon was not accompanied by a
leakage of the vesicles (not shown).
3.3.2. E¡ect of the surface ligand density
The sensitivity of the aggregation and leakage to
the surface density of the thiol-reactive functions,
and therefore on the amount of peptide that could
be coupled, was then studied. To that end PC/PG/
Chol/DPPE-PEG3-Mal liposomes were prepared in
which the relative proportions of DPPE-PEG3-Mal
were varied from 1.5 to 15 mol%. As indicated in
Fig. 3A, a threshold was observed at 1.5 mol% of
Fig. 4. Rates of reaction between peptide 1 with thiol-reactive
derivatives anchored in liposomes. The reactions were per-
formed at 25‡C in the presence of a two-fold molar excess of 1
vs. surface-exposed thiol-reactive derivatives with PC/PG/Chol/
DPPE-PEG3-Mal (65/20/50/15) (a) and PC/Chol/BOP-PEG4-
AcBr (85/50/15) (b) liposomes (100 WM (phospho)lipid ¢nal
concentration), in respectively 10 mM HEPES, 140 mM NaCl,
pH 6.5 and 40 mM sodium borate, 130 mM NaCl, pH 9.0 buf-
fers. Reaction progress was measured on aliquots by determina-
tion of residual peptide thiols with Ellman’s reagent; 100% rep-
resents the disappearance of 50% of added thiols corrected for
the spontaneous peptide oxidation (see text).
Fig. 3. Parameters in£uencing the release of CF from liposomes
by covalent coupling of peptide 1. Peptide 1 was added (25‡C)
to PC/PG/Chol/DPPE-PEG3-Mal (78.5^65/20/50/1.5^15) lipo-
somes, having encapsulated 40 mM CF, in 10 mM HEPES
bu¡er, 100 mM NaCl, pH 7.4. (A) The proportions of DPPE-
PEG3-Mal in the vesicles (100 WM) were 1.5 (a), 5 (b), 10 (c)
and 15 mol% (d) and 1 was added at 2 mol equivalents. (B) The
proportion of DPPE-PEG3-Mal in the vesicles was 15 mol%
and the liposomes (100 WM phospholipid) were reacted with 1 at
0.67 (a), 1.2 (b), 2 (c) and 3 (d) mol equivalents. These repre-
sentative time courses were recorded at 520 nm (see Fig. 1A).
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the thiol-reactive lipid derivative; thus essentially no
leakage of the vesicles that contained CF was mea-
surable on addition of peptide 1 whereas when con-
jugated at 5 mol% the leakage remained still mini-
mal. Loss of internal content became really
important at 10 mol% of DPPE-PEG3-Mal and at
15 mol% it plateaued at about 15%. Interestingly, a
correlation between the initial rates of vesicle leakage
and its ¢nal extent seems to exist (Fig. 3A). Next,
liposomes that contained 15 mol% DPPE-PEG3-Mal
were reacted with varying amounts of peptide 1. We
have shown before that this type of reaction could be
analyzed, in ¢rst approximation, by second-order
rate equations [27]. As shown in Fig. 3B, an apparent
correlation of the leakage rates ^ and extent ^ with
the concentration of the peptide, i.e. its rate of cou-
pling, could indeed be observed. The smallest leakage
rate was found with a sub-optimal concentration of
the peptide, i.e. with 0.66 eq. of 1, which, assuming
that the coupling is quantitative, would be equivalent
to the rate observed with vesicles containing about
10 mol% of DPPE-PEG3-Mal. This seems to be the
case: compare Fig. 3A and B.
Altogether these observations indicate that: (i) the
rate and extent of membrane destabilization are de-
pendent on the density of the conjugated peptides,
(ii) a minimal peptide density (s 5 mol%) must exist
on the surface of the vesicles to observe the leakage,
and importantly, (iii) K-MSH-targeted vesicles can be
made that do not readily aggregate, albeit with a
limited surface ligand density (V5 mol%).
3.4. Correlation between rates of aggregation/leakage
of the liposomes and the rate of covalent coupling
of the K-MSH analogs
To demonstrate the potential correlation between
covalent coupling of peptides 1 to the surface of the
vesicles with their aggregation/leakage we have taken
advantage of the di¡erence of reactivity, in aqueous
media, of the maleimide and bromoacetyl groups
with thiols carried by e.g. peptides. Thus in the
6.5^7.5 pH range the maleimide reacts very rapidly
and quantitatively whereas, comparatively, the bro-
moacetyl reacts much more slowly [27]. To observe
Table 3
Tryptophan £uorescence blue shift and £uorescence anisotropy
of peptides 1 and 2, either free in the presence of liposomes or
liposome-coupleda
Conditions vVmax ( þ 2 nm)b Anisotropy values
(r þ 0.002)
Peptide Peptide
1 2 1 2
PC/Chol/BOP-PEG4-AcBr (85/50/15)
Free peptide NSc NS 0.032 0.030
Coupled peptide 3.0 4.5 0.054 0.050
PC/PG/Chol/DPPE-PEG3-Mal (65/20/50/15)
Free peptide NS NS 0.024 0.019
Coupled peptide 9.0 10.5 0.082 0.075
PC/PG/Chol/DPPE-AcBr (65/20/50/15)
Free peptide NS NS 0.020 0.020
Coupled peptide NS NS 0.040 0.040
PC/PG/Chol/DPPE-PEG45-Mal (70/20/50/10)
Free peptide ^ ^ 0.031 0.023
Coupled peptide ^ ^ 0.037 0.043
aLiposomes (100 WM (phospho)lipids) and 1 mol eq. peptide vs.
thiol-reactive anchor were in B1 bu¡er pH 6.5 or B2 bu¡er pH
9.0, at 25‡C. Coupling time: 60 min (maleimide) and 90 min
(bromoacetyl). Free peptides were incubated similarly with con-
trol liposomes, i.e. vesicles in which the thiol-reactive functions
were ¢rst reacted with 2-mercaptoethanol or which lacked the
thiol-reactive anchors.
bIn the absence of lipids (in bu¡er solution), all peptides dis-
play a Vmax = 352 þ 2 nm.
cNot signi¢cant.
Fig. 5. Representative time course of internal content mixing
upon coupling of K-MSH analog. Peptide 1 was added (arrow)
at a 1.5:1 molar ratio vs. surface-exposed thiol-reactive function
(25‡C) to a 1:1 mixture in 10 mM HEPES bu¡er (pH 6.5) con-
taining 145 mM NaCl of liposomes (PC/PG/Chol/DPPE-PEG3-
Mal; 65/20/50/15) containing either 25 mM ANTS or 90 mM
DPX (¢nal phospholipid concentration: 100 WM). The quench-
ing of ANTS £uorescence due to the formation of the ANTS/
DPX complex was monitored at 505 nm (excitation 355 nm).
The initial £uorescence was taken as 100% and the minimal
£uorescence (maximal quenching), corresponding to a 100%
leakage-free fusion, was obtained with a preparation of lipo-
somes containing coencapsulated ANTS and DPX (see text).
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the coupling of the latter group, basic pH must be
used (e.g. pH 9.0). In Fig. 4 are represented the cou-
pling of 1 (2 molar eq.), at 25‡C, to liposomes con-
taining 15 mol% of DPPE-PEG3-Mal or BOP-PEG4-
AcBr at pH 6.5 and 9.0 respectively. In agreement
with our previous observations [27], in the ¢rst case
the coupling took place within 6^8 min whereas in
the second it plateaued after 40^60 min. The extent
of peptide coupling is similar in both cases and es-
sentially all the thiol-reactive groups present at the
surface of the vesicles had reacted. Under neutral
conditions, where the coupling of peptides 1 to
BOP-PEG4-AcBr takes place at very slow rates, es-
sentially no aggregation or leakage of the vesicles
could be observed (not shown); however, a good
correlation could be found between the coupling of
the peptides to the liposomes containing DPPE-
PEG3-Mal and their aggregation/leakage (compare
Figs. 4 and 1A,B). For the zwitterionic vesicles, how-
ever, the leakage occurs faster that the complete cou-
pling of e.g. peptide 1. It seems therefore that if the
coupling of the peptide to the surface of the lipo-
somes is a prerequisite for their aggregation/leakage
a limited amount (6 15 mol%) is enough to trigger
these phenomena.
3.5. Leakage and aggregation are correlated with
liposome fusion
The occurrence of a loss of liposomal content that
is correlated with an aggregation of the vesicles can
be indicative of fusion events. We therefore wanted
to verify whether the K-MSH analog used in this
study, through destabilization of the membrane bi-
layers, was endowed with fusogenic properties. In a
¢rst approach the fusion of liposomes was studied by
monitoring lipid mixing. This was classically deter-
mined by monitoring the decrease in resonance en-
ergy transfer (RET) between the £uorescently labeled
lipids N-Rh-PE and N-NBD-PE, present in the same
vesicles, as estimated by an increase in the N-NBD-
PE signal due to the fusion with unlabeled liposomes
present in excess (nine-fold). This probe dilution as-
say was chosen for its relative insensitivity to the
aggregation of vesicles [31]. As shown in Fig. 1C,
the addition of peptide 1 to a mixture of the two
vesicles populations which both contained a thiol-re-
active lipid derivative provoked a lipid mixing indica-
tive of fusion. The extent of fusion was dependent on
the composition of the liposomes; thus for the neg-
atively charged vesicles PC/PG/Chol/DPPE-PEG3-
Mal (65/20/50/15), a 24% increase in the £uorescence
of N-NBD was observed within the time frame used
whereas for the neutral vesicles PC/Chol/BOP-PEG4-
AcBr (85/50/15) this increase was 38%. These results,
which point to the occurrence of a fusion triggered
by peptide 1, correlate well with the observations
made above that leakage of the vesicles is more pro-
nounced in the zwitterionic vesicles as compared to
the negatively charged ones. Using the present assay
we also found that covalent coupling of 1 to the
surface of the vesicles was a prerequisite for observ-
ing a lipid mixing indicative of the vesicle fusion.
Thus, in control experiments addition of 1 to lipo-
somes that were devoid of thiol-reactive (phospho)-
lipid anchors did not lead to measurable increases of
N-NBD £uorescence (not shown). Interestingly, com-
parison of Fig. 1A and C shows a fairly good corre-
lation between leakage and fusion. This conclusion
was substantiated by the observation that liposomes
containing the thiol-reactive derivative DPPE-AcBr,
which have been shown above to undergo a very
limited aggregation and fusion when reacted with 1,
Fig. 6. Stern^Volmer plots of tryptophan £uorescence quench-
ing by I3 of the K-MSH analogs. Peptides 1 (b, a) and 2 (F,
E) and liposomes (PC/PG/Chol/BOP-PEG4-AcBr; 75/20/50/5)
were incubated for 90 min in 40 mM borate bu¡er, 130 mM
NaCl (pH 9.0), at 25‡C, before measurement. Trp £uorescence
intensity of free peptides (closed symbols) or coupled to lipo-
somes (open symbols) was recorded at 340 nm (Vexc = 280 nm)
in the presence of increasing concentrations of KI and were
corrected for the scattered blank of vesicles. The results are ex-
pressed as F0/F, where F0 denotes the £uorescence intensity in
the absence and F the £uorescence intensity in the presence of
the aqueous quencher. Phospholipid concentration 100 WM;
peptide concentration 2.5 WM.
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did not fuse according to the lipid mixing assay (not
shown).
In contrast to the other liposomes, with the stealth
vesicles (PC/PG/Chol/DPPE-PEG45-Mal; 70/20/50/
10), after 1 h in the presence of the peptides we
observed only 3% lipid mixing (not shown) which
correlates well with their lack of leakage (see above).
According to Basan‹ez et al. [40], the extent of lipid
mixing is reduced up to 40-fold in the presence of 6%
of PEG45 chains at the surface of liposomes. More-
over, the fusion between the vesicles is completely
suppressed.
We next assessed the fusion with the same lipid
mixing assay using this time an excess of unlabeled
liposomes that were devoid of thiol-reactive lipid deriv-
atives. Under these conditions, addition of peptide 1
to a 1:9 mixture of labeled PC/PG/Chol/DPPE-
PEG3-Mal (65/20/50/15) and unlabeled PC/PG/Chol
(80/20/50) liposomes did no lead to an observable
increase of N-NBD £uorescence (not shown). This
result, which could be correlated with a much re-
duced aggregation and leakage, is of special interest
and indicates that most probably the fusion triggered
by 1 occurs preferentially between liposome popula-
tions that carry the peptide at their surface. In the
present experimental setting this residual fusion re-
mains silent because it does not result in a probe
dilution, and this despite the presence of a nine-
fold excess of putative ‘target’ vesicles that carry no
peptide. It therefore seems probable that a speci¢c
interaction of 1 with the bilayers of the vesicles, to
which these peptides are covalently bound, is respon-
sible for these liposomes to become fusion-compe-
tent.
Altogether, these results indicate that the aggrega-
tion of the vesicles that is triggered by the peptide 1
results, in the non-stealth liposomes, into a fusion
which in this particular case is also accompanied
by a leakage of their content. At present it is di⁄cult
to conclude whether fusion and vesicle destabiliza-
tion resulting in leakage are in competition, if the
fusion triggered by these peptides is leaky, or if the
observed leakiness results from the destabilization of
bigger vesicles resulting from multiple rounds of fu-
sion, etc. To answer these questions we next studied
the fusion events by monitoring liposome content
mixing. This study was also useful to con¢rm that
the lipid mixing observed above was due to true fu-
sion and not to artifacts such as probe exchange or
membrane hemifusion between the outer layers of
the vesicles. The fusion assay was performed accord-
ing to a classical approach using with two types of
liposome populations, one containing the probe
ANTS and the other the quencher DPX [32]. For-
mation of the ANTS/DPX complex in the lumen of
the fused vesicles results in the quenching of the
ANTS £uorescence whereas the £uorescence that is
measured results from the addition of the £uores-
cence of non-fused liposomal ANTS and free
ANTS resulting from the leakage of either the
ANTS/DPX complex and encapsulated ANTS. On
addition of peptide 1 to these liposomes, which
both contain a thiol-reactive derivative, an immedi-
ate reduction of about 10% of the £uorescence was
measurable (Fig. 5), which is indicative of the occur-
rence of a limited fusion event leading to sealed
vesicles. This ¢rst phase is followed by a much slower
decrease in £uorescence whose low magnitude com-
pared to the one expected by the lipid mixing assay
(see above) most probably underlines the leakiness of
this fusion event.
3.6. Membrane active properties of peptide 2
The same types of experiments as described above
for peptide 1 were performed in parallel with the
shorter K-MSH analog 2. Altogether the results
were qualitatively similar but peptide 2 is less active
than 1 in promoting the aggregation and leakage of
the vesicles. There was, however, one noticeable dif-
ference: liposomes containing DPPE-AcBr, the thiol-
reactive derivative with a very short spacer, were
much more resistant to aggregation and leakage
(i.e. no leakage was observed) on coupling to peptide
2 than to 1. It seems therefore that the length and the
local mobility of the peptide at the surface of the
vesicles could represent crucial factors in their desta-
bilizing interaction with the membranes. Similarly
the extent of lipid mixing in the fusion assay was
less pronounced with 2 than with 1 (e.g. with the
neutral liposomes the coupling of peptide 2 resulted
in a 10% quenching relief compared to 38% with 1).
3.7. Interaction of K-MSH analogs with membranes
Membrane fusion triggered by small peptides has
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been documented in which hydrophobic interactions
are important elements in the mechanisms involved.
To determine whether 1 and 2 interact with the bi-
layers we have studied the changes in the £uores-
cence emission peak (Vmax) of their single tryptophan
residue when the peptides were conjugated to the
liposomes. The emission maximum shifts to lower
wavelength (blue shift) as the polarity of the environ-
ment decreases. Thus, if the tryptophan is shielded
from the solvent by insertion into the lipid bilayer,
the resulting blue shift could be used to follow the
degree of insertion. Besides, an increase in trypto-
phan £uorescence anisotropy could also be related
to a reduced mobility of the tryptophan residue in-
teracting with the membrane.
The results given in Table 3 indicate that blue
shifts of the £uorescence emission spectra of the tryp-
tophan residue of 1 and 2 could be observed with
vesicles containing the BOP-PEG4-AcBr or DPPE-
PEG3-Mal anchors; these shifts are accompanied,
in liposomes that do not undergo aggregation (i.e.
[ligand] = 5 mol%), by an increase of the tryptophan
£uorescence anisotropy, indicating a restriction in
the mobility of the peptides. Especially the most im-
portant blue shift observed with the negatively
charged vesicles (about 10 nm) is well correlated
with the higher £uorescence anisotropy value. These
data indicate that after covalent binding to the lipo-
somes, the tryptophan of the peptides migrates from
a highly polar (the bu¡er) to a less polar environ-
ment, with more restricted movements. However,
this blue shift is still far from the one obtained for
a tryptophan deeply buried in the hydrophobic acyl
chain region of the bilayer (vV= 20^30 nm) [41]. A
10 nm blue shift clearly indicates that the average
environment is less polar than the bulk aqueous
phase, but signi¢cantly less hydrophobic than the
deep acyl chain region of the bilayer. In fact, both
vVmax and r stand comparison with values obtained
with the model derivative tryptophan octyl ester for
which the probable depth of penetration of the in-
dole ring was shown to be approximately 10 Aî
[42,43]. In the case of zwitterionic vesicle-coupled
peptides, the increase of both blue shift and £uores-
cence anisotropy is less pronounced, but nevertheless
perceptible. These small variations could be ex-
plained by some sticking and/or partial sinking of
the peptide at the membrane interface. In contrast,
vesicles that carry a short spacer arm (AcBr) or in
contrast a very long one (PEG45) do not show any
blue shift; moreover, although an increase of r was
measurable for the conjugated peptides, the di¡er-
ence with the free peptides was not as large even as
it was in the neutral vesicles. This slight change in r is
more probably due to the loss of degree of freedom
due to covalent binding rather than to some interac-
tion with the bilayer interface. These results on the
incidence of the spacer arm lengths correlate well
with those obtained with the aggregation, leakage
and fusion studies (see above).
To further probe the location of the tryptophan
residue of 1 and 2 on the bilayers, we also studied
the quenching of the £uorescence of this residue by
hydrophilic agents such as KI. Quenching experi-
ments can reveal accessibility of £uorophores to
quenchers, and iodide ion is considered to have ac-
cess only to tryptophans exposed to the solvent. For
these experiments, in order to avoid the screening of
the conjugated peptides, we prepared vesicles (PC/
PG/Chol/BOP-PEG4-AcBr; 75/20/50/5) that contain
lower proportions of the thiol-reactive anchor and
thus avoid their aggregation. As shown in Fig. 6,
the quenching of the tryptophan £uorescence by KI
is lower when the peptides are coupled to the
vesicles, suggesting that in this latter case this residue
after being fully exposed becomes less accessible to
the aqueous environment presumably because of its
masking by a (at least partial) penetration into the
membrane. Moreover, the di¡erence of accessibility
for each peptide as probed by iodide quenching is
fully coherent with the location of the tryptophan
residues as inferred by blue shift and £uorescence
anisotropy measurements.
4. Discussion
In this work, we have shown that chemical cou-
pling of short positively charged superpotent K-MSH
analogs, of seven and 13 residues (Table 1) to the
surface of preformed zwitterionic (PC/Chol) or neg-
atively charged (PC/PG/Chol) liposomes results in a
rapid and extensive aggregation of the vesicles. These
phenomena, which were accompanied by membrane
destabilization (leakage) and fusion, were only ob-
served when a covalent linkage had occurred to the
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interacting bilayers. Thus, free peptides 1 or 2, even
at a 20-fold molar excess compared to the concen-
tration of bound peptides, were unable to cause sim-
ilar e¡ects. In agreement with this point, kinetic stud-
ies of the conjugation of the peptides to the thiol-
reactive groups present at the surface of the lipo-
somes indicated a good correlation between this re-
action and the observed aggregation/leakage of the
vesicles. The presently described membrane-active ef-
fects of melanotropin peptides such as 1 and 2 has
never been documented before. It therefore seems
likely that in the absence of a strong electrostatic
attraction of these peptides to the vesicles, the cova-
lent coupling to the outer layer of the bilayer pro-
vides a high local concentration of 1 and 2 which
might result in a particularly important membrane-
perturbing e¡ect. Such a dramatic increase in mem-
brane-destabilizing activity of a small peptide when
coupled to hydrophobic anchors has been observed
before, see e.g. [44].
Several observations are of importance to better
understand the e¡ects of melanotropin peptides on
membranes. When the thiol-reactive anchors
amounted to 15 mol% of total phospholipids, the
aggregation of the liposomes caused by peptides 1
and 2 was correlated with a leakage of their inner
aqueous contents. These two e¡ects were fairly in-
sensitive to the global charge of the vesicles, to the
nature of their phospholipid acyl chains and to a
range of pH typically known to regulate the activity
of pH-sensitive fusogenic peptides [45]. Among the
di¡erent liposomes studied, those prepared with zwit-
terionic lipids were, however, the most prone to leak-
age. It is therefore possible that, in contrast to the
charged vesicles which are somewhat less sensitive to
aggregation because of charge/charge repulsion, the
neutral ones can undergo more extensive vesicle^
vesicle interactions and destabilization. Lipid mixing
and content mixing assays were used in conjunction
to obtain rates of membrane destabilization and fu-
sion; we have thus established that the aggregation/
leakage observed with 1 and 2 were correlated with
the fusion of the vesicles. It seems therefore that the
aggregation triggered by covalent coupling of the
peptides is indicative of a profound perturbation of
the membrane structure leading to the bilayer fusion;
this latter process, which is accompanied by leakage
of the aqueous content of the vesicles, is therefore
not as ‘tight’ as the fusion observed for example by
the group of Hoekstra. These authors have exten-
sively studied the fusion of vesicles triggered by the
covalent coupling, via a disul¢de bond, to the surface
of preformed PC liposomes of a 11 amino acid am-
phipathic negatively charged peptide [46^50]. In their
case, however, the fusion occurred only between lipo-
somes carrying the peptide and positively charged
‘target’ vesicles with which they interact ¢rst because
of charge complementarity. In our study the aggre-
gation/fusion is not correlated with electrostatic in-
teractions between the vesicles and, strikingly, the
fusion is only observed between liposomes that carry
the peptides 1 or 2. Thus, in the lipid mixing fusion
assay no decrease of RET could be observed when
N-NBD-PE/N-Rh-PE-labeled vesicles, which were
conjugated to 1, were mixed at a 1:9 ratio with un-
labelled vesicles (i.e. devoid of the £uorescent labels)
that did not carry the peptide. It seems therefore that
for the vesicles to undergo aggregation/fusion both
partners must experience a modi¢cation of their bi-
layers by the conjugation of the peptide. Although
the results of the ANTS/DPX content mixing assay
are in favor of true vesicle fusion and not just a
mixing of external lea£ets, the release of the vesicles’
internal contents observed during these events some-
what limits the conclusions that can be drawn. We
certainly underestimate the extent of fusion triggered
by 1 or 2 and presently it is di⁄cult to delineate
whether the leakage is due to non-tight fusion events
or to a lack of stability of large vesicles resulting
from multiple rounds of fusion.
A second set of observations relates to the depen-
dence of the aggregation/leakage/fusion on the den-
sity of ligands 1 and 2 conjugated to the surface of
the vesicles and on the length of the spacer arms that
separate these peptides from the membrane bilayers.
A threshold was observed and at a density of less
than 5 mol% of peptide vs. total phospholipid, little
vesicle destabilization was measurable under our ex-
perimental conditions (Fig. 3). This indicates that a
relatively high concentration of peptide must be
present on the liposome surface to become mem-
brane-active. This destabilization was also found to
be much dependent on the spacer arm length. Thus,
a very short linker such as in DPPE-AcBr mostly
abolishes the phenomenon with peptide 2 and limits
the e¡ectiveness of the longer peptide 1. It seems
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therefore that both peptides 1 and 2 need a minimal
freedom of motion and orientation at the surface of
the bilayers to engage in their membrane-destabiliz-
ing e¡ects. At this level it should also be noted that
the shorter peptide 2, which contains the minimal
‘message sequence’ of the melanotropin peptides, is
somewhat less active than the analog 1 in triggering
the aggregation/fusion of the vesicles. In sharp con-
trast with all the foregoing results, when 1 or 2 were
conjugated to the surface of liposomes via a very
long spacer such as PEG45 no leakage/fusion could
be observed but aggregation was still measurable.
This uncoupling of aggregation and leakage in this
special case bears out our previous conclusions that
the leakage of the vesicles results from fusion events.
The absence of fusion of vesicles that contain DPPE-
PEG45-Mal by coupling the peptides is not surprising
since the PEG layer is well known to hinder such
events in sterically stabilized vesicles [51,52]. How-
ever, the persistence of an aggregation of our
DPPE-PEG45-Mal-containing liposomes is more puz-
zling, revealing either a penetration/perturbation of
the bilayers to which the peptides are conjugated
and/or the bridging of the vesicles via peptide^pep-
tide interactions.
The mechanisms by which peptides 1 and 2 are
able to trigger the aggregation/fusion of the lipo-
somes to which they become covalently attached
are at the present level of our study more di⁄cult
to decipher. It should be noted that the liposome
systems used here are not especially fusogenic, i.e.
they contain limited proportions ^ or no ^ of anionic
phospholipids and are devoid of PE. Both peptides
are water-soluble and bear respectively +2 and +1
charges, at least at neutral pH values, and their
mean hydrophobicities estimated with the Eisenberg
consensus scale [53] are about 30.15 and 30.2.
These values are somewhat lower than the average
hydrophobicity of e.g. viral N-terminal fusion pep-
tides [50]. The melanotropin peptides 1 and 2 are
also characterized by the presence of bulky hydro-
phobic amino acids which confer to them a certain
degree of amphipathy but from a structural view-
point they are too short to cross a membrane. The
three-dimensional structure of the melanotropin hor-
mones, including the analogs used here, have been
determined either by molecular dynamics or by
NMR. A consensus structure was established char-
acterized by the presence of a L-turn-like motif in the
middle of the K-MSH molecule that involves pre-
cisely the residues His6-L/D-Phe7-Arg8-Trp9 that are
necessary for the receptor binding and biological ac-
tivity (‘message sequence’) [54,55]. This conformation
is even more pronounced with the D-Phe7 analogs
[56]. An interesting feature which emerges is that
this domain forms a continuous hydrophobic surface
and it has been suggested that it interacts with hy-
drophobic counterparts on the MC1R. Arg8 is also
believed to point its positively charged side chain
towards ionized Asp and Glu residues belonging to
the transmembrane domains 2 and 3 of the receptor
which have been shown by site-directed mutagenesis
to be important for its function [7].
As mentioned in Section 1 the interaction of K-
MSH and its analogs with membranes has already
been studied [10^14]. With negatively charged
vesicles the peptide was found to interact ¢rst elec-
trostatically, this step being followed by a subsequent
penetration of the peptide into the hydrophobic core
of the bilayer. The depth of this penetration is still a
matter of debate and the interpretations depend on
the biophysical techniques used and on the peptide
structure, e.g. [NDP]-K-MSH was found to perturb
the membranes more than K-MSH itself [13]. The
spontaneous partitioning of peptides such as 1 and
2 into the bilayers of liposomes once they are cova-
lently linked to their surface ^ provided that the
spacer arm is long enough ^ has been clearly borne
out by our present studies. Indeed, the conjugation
step circumvents the necessity of electrostatic inter-
actions to bring the peptides in close contact with the
membranes and permits the study of interactions
with bilayers of di¡erent composition. The Trp resi-
dues of 1 and 2, which belong to the L-turn motif
and the active domain of the hormones, were con-
veniently used as £uorescent probes of their interac-
tion with the membranes. The shift to a shorter
wavelength of their emission maxima clearly indi-
cated that these peptides insert in the more hydro-
phobic acyl chain region of the lipid bilayers. Inter-
estingly, this e¡ect was as pronounced in 1 and 2,
suggesting that in the longer peptide the Trp residue
is buried to a similar extent despite the di¡erence in
potency between both peptides in triggering the ag-
gregation/leakage/fusion of the liposomes. This par-
titioning into the membranes was con¢rmed by a
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change in £uorescence anisotropy of the anchored
peptides and by the study on the changes of Trp
£uorescence quenching by soluble, aqueous-phase
I3 quencher. Altogether, it is very likely that the
covalent binding of 1 and 2 to the surface of the
liposomes results in their insertion into the bilayers.
The three-dimensional model that was proposed for
the mode of interaction of the melanotropin hor-
mones with their receptor could also be extended
to the insertion of the peptides 1 and 2 into mem-
branes; thus the L-turn domain could insert its hy-
drophobic residues ^ which include Trp9 ^ within the
hydrophobic core of the bilayers whereas Arg8 could
position its guanidinium as a counter-ion of a surface
phosphate headgroup. It should be noted that, as
proposed by Pascutti et al. [57], this particular con-
formation could be stabilized by the membrane’s low
dielectric constant environment.
The mechanism by which the insertion of 1 and 2
is translated into an alteration of the physical prop-
erties of membranes resulting in the aggregation and
fusion of the liposomes that carry these peptides re-
mains at the moment a matter of speculation. A vast
literature is devoted to the mode of action of fuso-
genic peptides which encompass a large variety of
structures and conformations, see e.g. [18]. In line
with the preferred L-structure of 1 and 2, peptides
adopting L-sheet or L-hairpin conformations have
been found to display fusogenic activity [58^60].
Moreover, Pe¤cheur et al. have shown that for their
11-mer peptides a helical structure is not su⁄cient to
observe fusion; in contrast, segregation of hydro-
philic and hydrophobic amino acids seems to be
more important [47]. Therefore, the asymmetric dis-
tribution of hydrophilic and hydrophobic amino
acids in peptides 1 and 2, which is thought to play
a key role in conferring membrane-destabilizing and,
eventually, fusion properties to peptides [15,61],
could be an important factor.
In conclusion, the membrane-active properties of
the K-MSH analogs we have uncovered are of inter-
est from a membrane biophysical viewpoint. Peptides
1 and 2 represent additional examples of peptides too
small to span a membrane that become fusogenic,
provided they are covalently bound to membranes
[44,46^50]. Our work also extends the earlier obser-
vations on the interaction of melanotropins with
liposomal and natural membranes by showing the
existence of membrane perturbations much larger
than anticipated. Such e¡ects could be relevant to
the biological mode of action of these peptides. In-
deed, in the 1980s Schwyzer et al. [62,63] have postu-
lated that K-MSH by interaction with the lipid phase
might trigger structural modi¢cations in the mem-
brane-spanning domains of their receptor and thus
enhance the peptide^receptor interaction and activ-
ity. Finally, because of their properties, these K-MSH
analogs could also be of interest in the design for
example of gene/drug delivery constructs and ful¢ll
a dual mission: cell targeting and endosomal com-
partment destabilization [20].
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